- Tumors828
- Pathology624
- Pathologic Processes612
- Nervous System Diseases521
- Cancer504
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors828
- Pathology624
- Pathologic Processes612
- Nervous System Diseases521
- Cancer504
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- ER positive
- HER2 positive
- EGFR negative
- EGFR positive
- PR positive
- ALK negative
- PD-L1 negative
- KRAS positive
- BRAF positive
- ER negative
- PR negative
- BRAF negative
- ROS1 negative
- BRCA1 positive
- CD20 positive
- p16 positive
- ALK positive
- BRCA2 positive
- MET positive
- PIK3CA positive
- HLA positive
- ROS1 positive
- HR positive
- MYC positive
- p16 negative
- HLA-A positive
- IDH negative
- MET negative
- PALB2 positive
- RET positive
- TP53 positive
- BCR-ABL1 positive
- HBsAg positive
- Anti-dsDNA positive
- BCL2 positive
- NRAS positive
- RET negative
- TP53 negative
- dMMR positive
- ABCA4 positive
- ANA positive
- BCL6 positive
- BRCA positive
- CCND1 positive
- CFTR positive
- HLA negative
- HLA-A negative
- HPV negative
- IDH positive
- KRAS negative
- MSS positive
- NTRK negative
- NTRK positive
- RAS positive
- RB1 negative
- RB1 positive
- TROP2 negative
- TROP2 positive
- ctDNA positive
- APP positive
- BRCA1 negative
- BRCA2 negative
- C5 positive
- COL7A1 positive
- FGFR2 positive
- FMR1 positive
- MDM2 positive
- MGMT negative
- MMR positive
- MSI-H positive
- NF1 positive
- PSEN1 positive
- PSEN2 positive
- PTEN positive
- Philadelphia chromosome positive
- RAS negative
- RF positive
- RHO positive
- pMMR positive
- 11q negative
- 11q positive
- AKT negative
- ALPL positive
- ATM positive
- Aβ1-42 positive
- CLDN18.2 positive
- COL1A1 positive
- COL1A2 positive
- DLL3 positive
- DMD positive
- EBV positive
- ER/PR positive
- Ex19del positive
- FLT3 negative
- FOXO1 fusion negative
- GRN positive
- HBB positive
- HEXA positive
- HEXB positive
- HPV positive
- HPV16 positive
- HRAS positive
- HbSS positive
- IGHV positive
- JAK2 positive
- KIT positive
- L858R positive
- MGMT positive
- MLH1 positive
- MMR negative
- MSH2 positive
- MSH6 positive
- MSI-H negative
- NF2 positive
- NRAS negative
- PDE6A positive
- PDE6B positive
- PIK3CA negative
- PIK3CD positive
- PIK3R1 positive
- PKLR positive
- PMM2 positive
- PMS2 positive
- PTCH1 positive
- PTEN negative
- Philadelphia chromosome negative
- PiZZ positive
- RAF positive
- SMN1 positive
- SPINK5 positive
- T790M positive
- TTR positive
- anti-AChR positive
- anti-MuSK positive
- anti-PLA2R positive
- anti-Ro autoantibodies positive
- anti-Ro/SSA positive
- anti-Sm positive
- anti-Smith positive
- dMMR negative
- other sickle cell syndrome variants positive
- p53 positive
- t(11;14) positive
- β-thalassemia positive
- 12 negative
- 12 positive
- 13q negative
- 13q positive
- 16p11.2 deletion positive
- 17p negative
- 17p positive
- 19q negative
- 19q positive
- 1p negative
- 1p positive
- 1p/19q co-deletion positive
- 1p/19q loss positive
- 1p36 deletion positive
- 46 XX karyotype positive
- 5q SMA positive
- 5q-autosomal recessive SMA positive
- AAVrh74 antibody titers negative
- ABL-class fusion positive
- ABL-class fusions positive
- ABO negative
- ABO positive
- ACVR1 positive
- AChR positive
- AChR-Ab positive
- ADAMTS-13 negative
- ADAMTS-13 positive
- AFP positive
- AKT positive
- AKT1 positive
- APOL1 positive
- AQP4 positive
- Acetylcholine receptor antibody positive
- Anti-CCP-2 positive
- Anti-HBc IgM negative
- Anti-Ro/SS-A positive
- Anti-SSA (Ro) positive
- Anti-SSB (La) positive
- Anti-Smith antibodies positive
- Antinuclear antibody positive
- Aβ1-40 positive
- Aβ1-42/Aβ1-40 ratio positive
- B7-H6 positive
- BCL-2 positive
- BCL-6 positive
- BCR-ABL1 e13a2 positive
- BCR-ABL1 e14a2 positive
- BCR-ABL1 fusion positive
- BCR-ABL1IS positive
- BRCA negative
- BTK-C481 positive
- C1-INH functional activity positive
- C1-INH positive
- C10orf2 positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Therapy (except reconstruction)
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Beovu
- Biologic Anti-Neoplastic Agent
- Branch Retinal Vein Occlusion (BRVO)
- CD4+ > 350 cells/microliter for at least twelve months
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
3307 trials
1
2
3
…50